<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31636070</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-6596</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>20</Day></PubDate></JournalIssue><Title>Antimicrobial agents and chemotherapy</Title><ISOAbbreviation>Antimicrob Agents Chemother</ISOAbbreviation></Journal><ArticleTitle>Anti-inflammatory Compound Shows Therapeutic Safety and Efficacy against Flavivirus Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e00941-19</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/AAC.00941-19</ELocationID><Abstract><AbstractText>Flaviviruses comprise several medically important viruses, including Japanese encephalitis virus, West Nile virus, dengue virus (DENV), yellow fever virus, and Zika virus (ZIKV). A large outbreak of DENV and ZIKV occurred recently, leading to many cases of illness and death. However, despite decades of effort, we have no clinically specific therapeutic drugs against DENV and ZIKV. Previous studies showed that inflammatory responses play a critical role in dengue and Zika virus pathogenesis. Thus, in this study, we examined a series of novel anti-inflammatory compounds and found that treatment with compound 2d could dose dependently reduce viral protein expression and viral progeny production in HEK-293 and Raw264.7 cells infected with four serotypes of DENV and ZIKV. In addition, considering medication safety, compound 2d could not suppress cyclooxygenase-1 (COX-1) enzymatic activities and thus could prevent the side effect of bleeding. Moreover, compound 2d significantly inhibited COX-2 enzymatic activities and prostaglandin E<sub>2</sub> levels, associated with viral replication, compared to results with a selective COX-2 inhibitor, celecoxib. Furthermore, administering 5&#x2009;mg/kg compound 2d to DENV-2-infected AG129 mice prolonged survival and reduced viremia and serum cytokine levels. Overall, compound 2d showed therapeutic safety and efficacy <i>in vitro</i> and <i>in vivo</i> and could be further developed as a potential therapeutic agent for flavivirus infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 American Society for Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chuang</LastName><ForeName>Fu-Kai</ForeName><Initials>FK</Initials><AffiliationInfo><Affiliation>Penghu Branch of Tri-Service General Hospital, Penghu, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Shih-Ming</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Ching-Len</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan, Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>An-Rong</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lien</LastName><ForeName>Shu-Pei</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Yu-Lung</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>School of Public Health, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Tsung-Hsien</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Pei-Ling</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan, Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Ren-Jye</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>National Mosquito-Borne Diseases Control Research Center, National Health Research Institute, Miaoli, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Chih-Chin</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Yi-Jing</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Gu-Jiun</ForeName><Initials>GJ</Initials><Identifier Source="ORCID">0000-0003-4302-8196</Identifier><AffiliationInfo><Affiliation>Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yen</LastName><ForeName>Li-Chen</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan, Republic of China yenlichen1030@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Antimicrob Agents Chemother</MedlineTA><NlmUniqueID>0315061</NlmUniqueID><ISSNLinking>0066-4804</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052246">Cyclooxygenase 2 Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance UI="D051545">Cyclooxygenase 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>JCX84Q7J1L</RegistryNumber><NameOfSubstance UI="D000068579">Celecoxib</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068579" MajorTopicYN="N">Celecoxib</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051545" MajorTopicYN="N">Cyclooxygenase 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052246" MajorTopicYN="N">Cyclooxygenase 2 Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057507" MajorTopicYN="N">Mice, 129 Strain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067996" MajorTopicYN="N">RAW 264.7 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012449" MajorTopicYN="N">Safety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071244" MajorTopicYN="N">Zika Virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071243" MajorTopicYN="N">Zika Virus Infection</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anti-inflammatory compound</Keyword><Keyword MajorTopicYN="N">antiviral agents</Keyword><Keyword MajorTopicYN="N">dengue virus</Keyword><Keyword MajorTopicYN="N">flavivirus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31636070</ArticleId><ArticleId IdType="pmc">PMC7187576</ArticleId><ArticleId IdType="doi">10.1128/AAC.00941-19</ArticleId><ArticleId IdType="pii">AAC.00941-19</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lindenbach BD, Thiel H-J, Rice CM. 2007. Flaviviridae: the viruses and their replication, p 1101&#x2013;1152. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed, vol 1 Lippincott Williams &amp; Wilkins, Philadelphia, PA.</Citation></Reference><Reference><Citation>Wilder-Smith A, Ooi EE, Horstick O, Wills B. 2019. Dengue. Lancet 393:350&#x2013;363. doi:10.1016/S0140-6736(18)32560-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)32560-1</ArticleId><ArticleId IdType="pubmed">30696575</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy BR, Whitehead SS. 2011. Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol 29:587&#x2013;619. doi:10.1146/annurev-immunol-031210-101315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-031210-101315</ArticleId><ArticleId IdType="pubmed">21219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Baud D, Gubler DJ, Schaub B, Lanteri MC, Musso D. 2017. An update on Zika virus infection. Lancet 390:2099&#x2013;2109. doi:10.1016/S0140-6736(17)31450-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31450-2</ArticleId><ArticleId IdType="pubmed">28647173</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen LR, Jamieson DJ, Powers AM, Honein MA. 2016. Zika Virus. N Engl J Med 374:1552&#x2013;1563. doi:10.1056/NEJMra1602113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1602113</ArticleId><ArticleId IdType="pubmed">27028561</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos T, Rodriguez A, Almiron M, Sanhueza A, Ramon P, de Oliveira WK, Coelho GE, Badaro R, Cortez J, Ospina M, Pimentel R, Masis R, Hernandez F, Lara B, Montoya R, Jubithana B, Melchor A, Alvarez A, Aldighieri S, Dye C, Espinal MA. 2016. Zika Virus and the Guillain-Barre syndrome&#x2014;case series from seven countries. N Engl J Med 375:1598&#x2013;1601. doi:10.1056/NEJMc1609015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1609015</ArticleId><ArticleId IdType="pubmed">27579558</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoen B, Schaub B, Funk AL, Ardillon V, Boullard M, Cabi&#xe9; A, Callier C, Carles G, Cassadou S, C&#xe9;saire R, Douine M, Herrmann-Storck C, Kadhel P, Laou&#xe9;nan C, Madec Y, Monthieux A, Nacher M, Najioullah F, Rousset D, Ryan C, Schepers K, Stegmann-Planchard S, Tressi&#xe8;res B, Volum&#xe9;nie J-L, Yassinguezo S, Janky E, Fontanet A. 2018. Pregnancy outcomes after ZIKV infection in French territories in the Americas. N Engl J Med 378:985&#x2013;994. doi:10.1056/NEJMoa1709481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1709481</ArticleId><ArticleId IdType="pubmed">29539287</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott LJ. 2016. Tetravalent dengue vaccine: a review in the prevention of dengue disease. Drugs 76:1301&#x2013;1312. doi:10.1007/s40265-016-0626-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-016-0626-8</ArticleId><ArticleId IdType="pubmed">27506852</ArticleId></ArticleIdList></Reference><Reference><Citation>Munjal A, Khandia R, Dhama K, Sachan S, Karthik K, Tiwari R, Malik YS, Kumar D, Singh RK, Iqbal HMN, Joshi SK. 2017. Advances in developing therapies to combat Zika virus: current knowledge and future perspectives. Front Microbiol 8:1469. doi:10.3389/fmicb.2017.01469.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.01469</ArticleId><ArticleId IdType="pmc">PMC5541032</ArticleId><ArticleId IdType="pubmed">28824594</ArticleId></ArticleIdList></Reference><Reference><Citation>Low JG, Ooi EE, Vasudevan SG. 2017. Current status of dengue therapeutics research and development. J Infect Dis 215(Suppl 2):S96&#x2013;S102. doi:10.1093/infdis/jiw423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw423</ArticleId><ArticleId IdType="pmc">PMC5388029</ArticleId><ArticleId IdType="pubmed">28403438</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, Huang X, Hong W, Qiu S, Wang J, Yu L, Zeng Y, Tan X, Zhang F. 2016. Slow resolution of inflammation in severe adult dengue patients. BMC Infect Dis 16:291. doi:10.1186/s12879-016-1596-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-016-1596-x</ArticleId><ArticleId IdType="pmc">PMC4908683</ArticleId><ArticleId IdType="pubmed">27301555</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa VV, Fagundes CT, Souza DG, Teixeira MM. 2013. Inflammatory and innate immune responses in dengue infection: protection versus disease induction. Am J Pathol 182:1950&#x2013;1961. doi:10.1016/j.ajpath.2013.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2013.02.027</ArticleId><ArticleId IdType="pubmed">23567637</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathakrishnan A, Wang SM, Hu Y, Khan AM, Ponnampalavanar S, Lum L, Manikam R, Sekaran SD. 2012. Cytokine expression profile of dengue patients at different phases of illness. PLoS One 7:e52215. doi:10.1371/journal.pone.0052215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052215</ArticleId><ArticleId IdType="pmc">PMC3527385</ArticleId><ArticleId IdType="pubmed">23284941</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias J, Valero N, Mosquera J, Montiel M, Reyes E, Larreal Y, Alvarez-Mon M. 2014. Increased expression of cytokines, soluble cytokine receptors, soluble apoptosis ligand and apoptosis in dengue. Virology 452&#x2013;453:42&#x2013;51. doi:10.1016/j.virol.2013.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2013.12.027</ArticleId><ArticleId IdType="pubmed">24606681</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Weg CA, Pannuti CS, de Araujo ES, van den Ham HJ, Andeweg AC, Boas LS, Felix AC, Carvalho KI, de Matos AM, Levi JE, Romano CM, Centrone CC, de Lima Rodrigues CL, Luna E, van Gorp EC, Osterhaus AD, Martina BE, Kallas EG. 2013. Microbial translocation is associated with extensive immune activation in dengue virus infected patients with severe disease. PLoS Negl Trop Dis 7:e2236. doi:10.1371/journal.pntd.0002236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002236</ArticleId><ArticleId IdType="pmc">PMC3662706</ArticleId><ArticleId IdType="pubmed">23717702</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CK, Tseng CK, Wu YH, Liaw CC, Lin CY, Huang CH, Chen YH, Lee JC. 2017. Cyclooxygenase-2 facilitates dengue virus replication and serves as a potential target for developing antiviral agents. Sci Rep 7:44701. doi:10.1038/srep44701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44701</ArticleId><ArticleId IdType="pmc">PMC5357798</ArticleId><ArticleId IdType="pubmed">28317866</ArticleId></ArticleIdList></Reference><Reference><Citation>Seynhaeve AL, Vermeulen CE, Eggermont AM, ten Hagen TL. 2006. Cytokines and vascular permeability: an in vitro study on human endothelial cells in relation to tumor necrosis factor-alpha-primed peripheral blood mononuclear cells. Cell Biochem Biophys 44:157&#x2013;169. doi:10.1385/CBB:44:1:157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/CBB:44:1:157</ArticleId><ArticleId IdType="pubmed">16456244</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprague AH, Khalil RA. 2009. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 78:539&#x2013;552. doi:10.1016/j.bcp.2009.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2009.04.029</ArticleId><ArticleId IdType="pmc">PMC2730638</ArticleId><ArticleId IdType="pubmed">19413999</ArticleId></ArticleIdList></Reference><Reference><Citation>Steer SA, Corbett JA. 2003. The role and regulation of COX-2 during viral infection. Viral Immunol 16:447&#x2013;460. doi:10.1089/088282403771926283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/088282403771926283</ArticleId><ArticleId IdType="pubmed">14733733</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsatsanis C, Androulidaki A, Venihaki M, Margioris AN. 2006. Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol 38:1654&#x2013;1661. doi:10.1016/j.biocel.2006.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2006.03.021</ArticleId><ArticleId IdType="pubmed">16713323</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Elia RV, Harrison K, Oyston PC, Lukaszewski RA, Clark GC. 2013. Targeting the &#x201c;cytokine storm&#x201d; for therapeutic benefit. Clin Vaccine Immunol 20:319&#x2013;327. doi:10.1128/CVI.00636-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00636-12</ArticleId><ArticleId IdType="pmc">PMC3592351</ArticleId><ArticleId IdType="pubmed">23283640</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellstein D, Fernandes L. 2019. Symptomatic treatment of dengue: should the NSAID contraindication be reconsidered? Postgrad Med 131:109&#x2013;116. doi:10.1080/00325481.2019.1561916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00325481.2019.1561916</ArticleId><ArticleId IdType="pubmed">30575425</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. 2009. Dengue: guidelines for diagnosis, treatment, prevention and control. WHO, Geneva, Switzerland.</Citation></Reference><Reference><Citation>Gan VC. 2014. Dengue: moving from current standard of care to state-of-the-art treatment. Curr Treat Options Infect Dis 6:208&#x2013;226. doi:10.1007/s40506-014-0025-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40506-014-0025-1</ArticleId><ArticleId IdType="pmc">PMC4431705</ArticleId><ArticleId IdType="pubmed">25999799</ArticleId></ArticleIdList></Reference><Reference><Citation>Baz M, Boivin G. 2019. Antiviral agents in development for Zika virus infections. Pharmaceuticals (Basel) 12:E101. doi:10.3390/ph12030101.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph12030101</ArticleId><ArticleId IdType="pmc">PMC6789597</ArticleId><ArticleId IdType="pubmed">31261947</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Reisch JS, Schiodt FV, Ostapowicz G, Shakil AO, Lee WM, Acute Liver Failure Study Group. 2005. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42:1364&#x2013;1372. doi:10.1002/hep.20948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.20948</ArticleId><ArticleId IdType="pubmed">16317692</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu WL, Ho LJ, Chang DM, Chen CH, Lai JH. 2009. Triggering of DC migration by dengue virus stimulation of COX-2-dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation. Eur J Immunol 39:3413&#x2013;3422. doi:10.1002/eji.200939306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200939306</ArticleId><ArticleId IdType="pubmed">19862774</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SM, Cheung CY, Nicholls JM, Hui KP, Leung CY, Uiprasertkul M, Tipoe GL, Lau YL, Poon LL, Ip NY, Guan Y, Peiris JS. 2008. Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J Infect Dis 198:525&#x2013;535. doi:10.1086/590499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/590499</ArticleId><ArticleId IdType="pubmed">18613795</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou JT, Chen ZY, Ho LJ, Yang SP, Chang DM, Liang CC, Lai JH. 2008. Differential effects of triptolide and tetrandrine on activation of COX-2, NF-kappaB, and AP-1 and virus production in dengue virus-infected human lung cells. Eur J Pharmacol 589:288&#x2013;298. doi:10.1016/j.ejphar.2008.04.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2008.04.056</ArticleId><ArticleId IdType="pmc">PMC7094504</ArticleId><ArticleId IdType="pubmed">18565510</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung S-T, Huang W-H, Huang C-K, Liu F-C, Huang R-Y, Wu C-C, Lee A-R. 2016. Synthesis and anti-inflammatory activities of 4H-chromene and chromeno[2,3-b]pyridine derivatives. Res Chem Intermed 42:1195&#x2013;1215. doi:10.1007/s11164-015-2081-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11164-015-2081-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JL, de Wet BJM, deWet BJM, Martinez-Pomares L, Radcliffe CM, Dwek RA, Rudd PM, Gordon S. 2008. The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog 4:e17. doi:10.1371/journal.ppat.0040017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.0040017</ArticleId><ArticleId IdType="pmc">PMC2233670</ArticleId><ArticleId IdType="pubmed">18266465</ArticleId></ArticleIdList></Reference><Reference><Citation>Weger-Lucarelli J, Duggal NK, Bullard-Feibelman K, Veselinovic M, Romo H, Nguyen C, Ruckert C, Brault AC, Bowen RA, Stenglein M, Geiss BJ, Ebel GD. 2017. Development and characterization of recombinant virus generated from a New World Zika virus infectious clone. J Virol 91:e01765-16. doi:10.1128/JVI.01765-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01765-16</ArticleId><ArticleId IdType="pmc">PMC5165210</ArticleId><ArticleId IdType="pubmed">27795432</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S, Cameron C, Andino R. 2002. Ribavirin&#x2019;s antiviral mechanism of action: lethal mutagenesis? J Mol Med (Berl) 80:86&#x2013;95. doi:10.1007/s00109-001-0308-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-001-0308-0</ArticleId><ArticleId IdType="pubmed">11907645</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothan HA, Buckle MJ, Ammar YA, Mohammadjavad P, Shatrah O, Noorsaadah AR, Rohana Y. 2013. Study the antiviral activity of some derivatives of tetracycline and non-steroid anti-inflammatory drugs towards dengue virus. Trop Biomed 30:681&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pubmed">24522138</ArticleId></ArticleIdList></Reference><Reference><Citation>Schul W, Liu W, Xu HY, Flamand M, Vasudevan SG. 2007. A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J Infect Dis 195:665&#x2013;674. doi:10.1086/511310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/511310</ArticleId><ArticleId IdType="pubmed">17262707</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyadarshini D, Gadia RR, Tripathy A, Gurukumar KR, Bhagat A, Patwardhan S, Mokashi N, Vaidya D, Shah PS, Cecilia D. 2010. Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. PLoS One 5:e8709. doi:10.1371/journal.pone.0008709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0008709</ArticleId><ArticleId IdType="pmc">PMC2806829</ArticleId><ArticleId IdType="pubmed">20090849</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang C-Y, Pan C-H, Hsieh C-H, Tsai J-P, Chen M-Y, Liu H-H, Liu S-J, Chong P, Leng C-H, Chen H-W. 2013. Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement. PLoS Negl Trop Dis 7:e2432. doi:10.1371/journal.pntd.0002432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002432</ArticleId><ArticleId IdType="pmc">PMC3777875</ArticleId><ArticleId IdType="pubmed">24069487</ArticleId></ArticleIdList></Reference><Reference><Citation>Simanjuntak Y, Liang JJ, Chen SY, Li JK, Lee YL, Wu HC, Lin YL. 2018. Ebselen alleviates testicular pathology in mice with Zika virus infection and prevents its sexual transmission. PLoS Pathog 14:e1006854. doi:10.1371/journal.ppat.1006854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006854</ArticleId><ArticleId IdType="pmc">PMC5814061</ArticleId><ArticleId IdType="pubmed">29447264</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh MS, Chen MY, Hsieh CH, Pan CH, Yu GY, Chen HW. 2017. Detection and quantification of dengue virus using a novel biosensor system based on dengue NS3 protease activity. PLoS One 12:e0188170. doi:10.1371/journal.pone.0188170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0188170</ArticleId><ArticleId IdType="pmc">PMC5697845</ArticleId><ArticleId IdType="pubmed">29161301</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>